JPRN-jRCT2080220368未知3 期
Double-blind, parallel-group confirmatory study of AD-810N (zonisamide) in patients with Parkinson's disease
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •[Major inclusion criteria]
- •- Patients with reduced response to L-DOPA
- •- Age: >=20 and <75 (at the time of informed consent)
- •[Major exclusion criteria]
- •- Patients with Parkinson's syndrome other than Parkinson's disease
- •- Patients with epilepsy
- •- Patients with a history of treatment with zonisamide, or who have ever enrolled in other clinical trials related to AD-810N
- •- Patients with a history of neuroleptic malignant syndrome
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Two-group, parallel, double-blind study to evaluate the effects of limonite intake on glucose metabolism during 12 weeks.Healthy person (high fasting blood glucose level, up to 125 mg / dl)JPRN-UMIN000039470Mie University, Graduate School of Medicine50
进行中（未招募）
不适用
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-InhibitorAdult Rheumatoid Arthritis (RA)MedDRA version: 13.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2010-023587-40-GRF. Hoffmann-La Roche Ltd.700
进行中（未招募）
不适用
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-InhibitorAdult Rheumatoid Arthritis (RA)MedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2010-023587-40-DEF. Hoffmann-La Roche Ltd.700
进行中（未招募）
不适用
Efficacy and Safety of RO4917523 as add-on therapy in patients with Major Depressive Disorder who have inadequate response to ongoing antidepressant medication.EUCTR2011-001436-33-DEF. Hoffmann-La Roche Ltd300
已完成
不适用
Rosemary anti-stress main studyhealthy personJPRN-UMIN000047500Clinical Creative Co., Ltd44